Paragon Therapeutics, Inc.

CIK 1861055 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Paragon Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Apr 23, 2026SCHEDULE 13G/A0001193125-26-174454
Jan 12, 2026SCHEDULE 13G0001193125-26-010344
May 10, 2021D0000897069-21-000219